drugset / Trial / NCT03959852

Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain

NCT03959852 ↗

Phase 4 Terminated 6 enrolled Mercy Health Ohio
RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of this study is to evaluate the potential opioid-sparing effect associated with the novel combination of fentanyl and sub-dissociative ketamine in adult patients with moderate to severe pain in the emergency department.

Timeline

Start
2019-11-18
Primary completion
2020-06-05
Completion
2020-06-05

Outcome

Outcome not reported

Stopped: “Residency completed.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 0.5 mg/kg Intravenous
Comparator Fentanyl Other / unclassified 1 mg/kg Intravenous
Comparator Ketamine Small molecule 0.15 mg/kg Intravenous
Comparator Ketamine Small molecule 0.3 mg/kg Intravenous

Indications

No indication recorded.